SERPINI1

Chr 3AD

serpin family I member 1

Also known as: HNS-S1, HNS-S2, PI12, neuroserpin

This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.641 OMIM phenotype
Clinical SummarySERPINI1
🧬
Gene-Disease Validity (ClinGen)
progressive myoclonus epilepsy · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 228 VUS of 405 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.64LOEUF
pLI 0.027
Z-score 2.68
OE 0.33 (0.180.64)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.42Z-score
OE missense 0.92 (0.821.03)
194 obs / 211.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.33 (0.180.64)
00.351.4
Missense OE?0.92 (0.821.03)
00.61.4
Synonymous OE?0.89
01.21.6
LoF obs/exp: 6 / 18.4Missense obs/exp: 194 / 211.2Syn Z: 0.70

This gene — mechanism propensity

DN
0.7132th %ile
GOF
0.7028th %ile
LOF
0.2093th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

405 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic1
VUS228
Likely Benign124
Benign30
Conflicting9
5
Pathogenic
1
Likely Pathogenic
228
VUS
124
Likely Benign
30
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
5
0
0
5
Likely Pathogenic
0
1
0
0
1
VUS
8
198
21
1
228
Likely Benign
0
11
45
68
124
Benign
0
5
22
3
30
Conflicting
9
Total82208872397

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

22 pathogenic / likely-pathogenic (of 28) ClinVar copy-number / structural variants overlap SERPINI1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SERPINI1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →